Australis Cap (AUSAF) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 6 69 sessions, March 4, 2025 to March 5, 2026
- Largest daily move
- +900% close of March 4, 2026
- 1-year change
- +0% closing prices, March 4, 2025 to March 5, 2026
Company Description
Australis Cap (OTC Link: AUSAF) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $5.8M.
AUSAF has gained 0.0% over the past year. The last closing price was $0.0001.
This page collects what Stock Titan holds for AUSAF, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Australis Cap (AUSAF) closed at $0.0001 on March 5, 2026. Over the past 12 months, the price has gained 0.0%.
AUSAF Metrics & Rankings
Price returns through March 5, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Australis Cap has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include earnings, management. View all AUSAF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Australis Cap (AUSAF) currently stands at 1.1 thousand shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Australis Cap (AUSAF) currently stands at 1000.0 days, up 8345.9% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 99899% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
AUSAF Company Profile & Sector Positioning
Australis Cap (AUSAF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing AUSAF often look at related companies in the same sector, including Bakhu Hold (BKUH), Elixinol Wellness Limited (ELLXF), Cls Holdings Usa (CLSH), Pharmacielo (PCLOF), and Stemsation International Inc (STSN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate AUSAF's relative position within its industry.